Testing effectiveness (Phase 2)Study completedNCT00749957
What this trial is testing
Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis
Who this might be right for
Leber Congenital Amaurosis
Beacon Therapeutics 12